Source:http://linkedlifedata.com/resource/pubmed/id/18293353
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
2008-4-3
|
pubmed:abstractText |
The synthesis and biological activity of three heteronuclear platinum-copper complexes based on 3-Clip-Phen are reported. These rigid complexes have been designed to alter the intrinsic mechanism of action of both the platinum moiety and the Cu(3-Clip-Phen) unit. The platinum centers of two of these complexes are coordinated to a 3-Clip-Phen moiety, an ammine ligand and two chlorides, which are either cis or trans to each other. The third complex comprises two 3-Clip-Phen units and two chloride ligands bound in a trans fashion to the platinum ion. DNA-cleavage experiments show that the complexes are highly efficient nuclease agents. In addition, a markedly difference in their aptitude to perform direct double-strand cleavage is observed, which appears to be strongly related to the ability of the platinum unit to coordinate to DNA. Indeed, complex 6 is unable to coordinate to DNA, which is reflected by its incapability to carry out double-strand breaks. Nonetheless, this complex exhibits efficient DNA-cleavage activity, and its cytotoxicity is high for several cell lines. Complex 6 shows better antiproliferate activity than both cisplatin and Cu(3-Clip-Phen) toward most cancer cell lines. Furthermore, the cytotoxicity observed for 1 is for most cell lines close to that of cisplatin, or even better. Cu(3-Clip-Phen) induces very low cytotoxic effects, but a marked migratory activity. Complex 6 presents DNA-cleavage properties comparable to the one of Cu(3-Clip-Phen), but it does not show any migratory activity. Interestingly, both Cu(3-Clip-Phen) and 6 induces vacuolisation processes in the cell in contrast to complex 1 and cisplatin. Thus, the four complexes cisplatin tested, Cu(3-Clip-Phen), 1 and 6 stimulate different cellular responses.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0947-6539
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3418-26
|
pubmed:dateRevised |
2009-8-4
|
pubmed:meshHeading |
pubmed-meshheading:18293353-Antineoplastic Agents,
pubmed-meshheading:18293353-Bacteriophage phi X 174,
pubmed-meshheading:18293353-Base Sequence,
pubmed-meshheading:18293353-Cell Line, Tumor,
pubmed-meshheading:18293353-Copper,
pubmed-meshheading:18293353-DNA, Viral,
pubmed-meshheading:18293353-Drug Screening Assays, Antitumor,
pubmed-meshheading:18293353-Humans,
pubmed-meshheading:18293353-Hydrolysis,
pubmed-meshheading:18293353-Magnetic Resonance Spectroscopy,
pubmed-meshheading:18293353-Platinum
|
pubmed:year |
2008
|
pubmed:articleTitle |
Platinated copper(3-clip-phen) complexes as effective DNA-cleaving and cytotoxic agents.
|
pubmed:affiliation |
Gorlaeus Laboratories, Leiden University, Leiden, The Netherlands.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|